BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 18926687)

  • 21. Antidiabetic effect of a novel non-thiazolidinedione PPAR gamma/alpha agonist on ob/ob mice.
    Hu X; Feng Y; Shen Y; Zhao XF; Yu JH; Yang YS; Leng Y
    Acta Pharmacol Sin; 2006 Oct; 27(10):1346-52. PubMed ID: 17007742
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MD001, a Novel Peroxisome Proliferator-activated Receptor α/γ Agonist, Improves Glucose and Lipid Metabolism.
    Kim SH; Hong SH; Park YJ; Sung JH; Suh W; Lee KW; Jung K; Lim C; Kim JH; Kim H; Park KS; Park SG
    Sci Rep; 2019 Feb; 9(1):1656. PubMed ID: 30733541
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel transcriptome profiling analyses demonstrate that selective peroxisome proliferator-activated receptor γ (PPARγ) modulators display attenuated and selective gene regulatory activity in comparison with PPARγ full agonists.
    Tan Y; Muise ES; Dai H; Raubertas R; Wong KK; Thompson GM; Wood HB; Meinke PT; Lum PY; Thompson JR; Berger JP
    Mol Pharmacol; 2012 Jul; 82(1):68-79. PubMed ID: 22496518
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Caulerpa okamurae extract inhibits adipogenesis in 3T3-L1 adipocytes and prevents high-fat diet-induced obesity in C57BL/6 mice.
    Sharma BR; Kim HJ; Kim MS; Park CM; Rhyu DY
    Nutr Res; 2017 Nov; 47():44-52. PubMed ID: 29241577
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel selective peroxisome proliferator-activator receptor-gamma modulator-SPPARgammaM5 improves insulin sensitivity with diminished adverse cardiovascular effects.
    Chang CH; McNamara LA; Wu MS; Muise ES; Tan Y; Wood HB; Meinke PT; Thompson JR; Doebber TW; Berger JP; McCann ME
    Eur J Pharmacol; 2008 Apr; 584(1):192-201. PubMed ID: 18346728
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amodiaquine improves insulin resistance and lipid metabolism in diabetic model mice.
    Jung HY; Kim B; Ryu HG; Ji Y; Park S; Choi SH; Lee D; Lee IK; Kim M; Lee YJ; Song W; Lee YH; Choi HJ; Hyun CK; Holzapfel WH; Kim KT
    Diabetes Obes Metab; 2018 Jul; 20(7):1688-1701. PubMed ID: 29516607
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Guggul for hyperlipidemia: a review by the Natural Standard Research Collaboration.
    Ulbricht C; Basch E; Szapary P; Hammerness P; Axentsev S; Boon H; Kroll D; Garraway L; Vora M; Woods J;
    Complement Ther Med; 2005 Dec; 13(4):279-90. PubMed ID: 16338199
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Osthole, a potential antidiabetic agent, alleviates hyperglycemia in db/db mice.
    Liang HJ; Suk FM; Wang CK; Hung LF; Liu DZ; Chen NQ; Chen YC; Chang CC; Liang YC
    Chem Biol Interact; 2009 Oct; 181(3):309-15. PubMed ID: 19682441
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Screening of medicinal plants for PPARα and PPARγ activation and evaluation of their effects on glucose uptake and 3T3-L1 adipogenesis.
    Yang MH; Avula B; Smillie T; Khan IA; Khan SI
    Planta Med; 2013 Aug; 79(12):1084-95. PubMed ID: 23877921
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chebulagic acid from Terminalia chebula enhances insulin mediated glucose uptake in 3T3-L1 adipocytes via PPARγ signaling pathway.
    Shyni GL; Kavitha S; Indu S; Arya AD; Anusree SS; Vineetha VP; Vandana S; Sundaresan A; Raghu KG
    Biofactors; 2014; 40(6):646-57. PubMed ID: 25529897
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel specific peroxisome proliferator-activated receptor γ (PPARγ) modulator YR4-42 ameliorates hyperglycaemia and dyslipidaemia and hepatic steatosis in diet-induced obese mice.
    Huan Y; Pan X; Peng J; Jia C; Sun S; Bai G; Wang X; Zhou T; Li R; Liu S; Li C; Liu Q; Liu Z; Shen Z
    Diabetes Obes Metab; 2019 Nov; 21(11):2553-2563. PubMed ID: 31364797
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Isomeric C12-alkamides from the roots of Echinacea purpurea improve basal and insulin-dependent glucose uptake in 3T3-L1 adipocytes.
    Kotowska D; El-Houri RB; Borkowski K; Petersen RK; Fretté XC; Wolber G; Grevsen K; Christensen KB; Christensen LP; Kristiansen K
    Planta Med; 2014 Dec; 80(18):1712-20. PubMed ID: 25371981
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An allosteric antibody to the leptin receptor reduces body weight and reverses the diabetic phenotype in the Lep(ob) /Lep(ob) mouse.
    Bhaskar V; Goldfine ID; Gerstner R; Michelson K; Tran C; Nonet G; Bohmann D; Pongo E; Zhao J; Horwitz AH; Takeuchi T; White M; Corbin JA
    Obesity (Silver Spring); 2016 Aug; 24(8):1687-94. PubMed ID: 27330016
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-fat diet induces leptin resistance in leptin-deficient mice.
    Koch CE; Lowe C; Pretz D; Steger J; Williams LM; Tups A
    J Neuroendocrinol; 2014 Feb; 26(2):58-67. PubMed ID: 24382295
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyclolepis genistoides D. Don (palo azul) promotes differentiation of adipocytes and regulates adipokine expression.
    Sato H; Ishikawa M; Funaki A; Kimura Y; Yoshida H; Fukata H; Hasegawa H; Ueno K
    Nutr Res; 2013 Nov; 33(11):922-31. PubMed ID: 24176232
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanism of the antiadipogenic-antiobesity effects of a rice hull smoke extract in 3T3-L1 preadipocyte cells and in mice on a high-fat diet.
    Kim SP; Nam SH; Friedman M
    Food Funct; 2015 Sep; 6(9):2939-48. PubMed ID: 26190448
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 5,7-Dihydroxy-6-geranylflavanone improves insulin sensitivity through PPARα/γ dual activation.
    Lee W; Yoon G; Kim MC; Kwon HC; Bae GU; Kim YK; Kim SN
    Int J Mol Med; 2016 May; 37(5):1397-404. PubMed ID: 26986637
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-diabetic effect of amorphastilbol through PPARα/γ dual activation in db/db mice.
    Lee W; Ham J; Kwon HC; Kim YK; Kim SN
    Biochem Biophys Res Commun; 2013 Mar; 432(1):73-9. PubMed ID: 23376064
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Guggulipid for the treatment of hypercholesterolemia: a randomized controlled trial.
    Szapary PO; Wolfe ML; Bloedon LT; Cucchiara AJ; DerMarderosian AH; Cirigliano MD; Rader DJ
    JAMA; 2003 Aug; 290(6):765-72. PubMed ID: 12915429
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of rosiglitazone on the differential expression of obesity and insulin resistance associated proteins in lep/lep mice.
    Sanchez JC; Converset V; Nolan A; Schmid G; Wang S; Heller M; Sennitt MV; Hochstrasser DF; Cawthorne MA
    Proteomics; 2003 Aug; 3(8):1500-20. PubMed ID: 12923776
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.